The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. The 3rd Inner Ear...
François Patou discusses how the recent advances in virtual reality technologies can be used to support people living with hearing loss. He outlines some of the novel virtual reality tools that are emerging as resources to support delivery of audiology...
Prof Valerie Lund caught up with friend and colleague, Prof Dr Metin Önerci, to discuss his various positions in rhinology, the FOAM programme with which he is involved, and rhinology in Turkey and the Balkan and the Central Asian region....
Presbycusis, or age-related hearing loss, is one of the most common conditions affecting older adults and its prevalence is found to increase with age. Over the years, amplification technology has advanced significantly from analogue to digital signal processing. Despite this,...
4 July 2024
| Juan Carlos Hernaiz, Sandeep K Gill, Amee R Manges, Amin R Javer
|
ENTA - Rhinology / Sinus
Researchers at St Paul’s Sinus Centre and UBC in Vancouver are testing a novel treatment for CRS: transferring mucus from a healthy donor into a patient’s sinuses. Chronic rhinosinusitis (CRS) is one of the most common diseases managed by otolaryngologists...
4 March 2024
| Will Wakeford, Aaron Trinidade, Codruta Neumann
|
ENTA - Head & Neck
Chronic ear disease can be challenging to manage and difficult for patients to live with. In this article, the authors describe their technique for otomastoid obliteration and blind sac closure of the external canal allowing for a more tolerable situation...
The loss of sound input from one ear has a significant impact on our perception of our acoustic environment. This impact is compounded in adverse listening conditions. Rachel Knappett’s article explores the audiological impact of this hearing loss and the...
Smell has long been regarded as the Cinderella of the senses, oft neglected by clinicians, the research community and lay public. The Global Consortium for Chemosensory Research looks to change all that. Our roving reporter, Abigail Walker, talks to its...
Smell has long been regarded as the Cinderella of the senses, oft neglected by clinicians, the research community and lay public. The Global Consortium for Chemosensory Research looks to change all that. Our roving reporter, Abigail Walker, talks to its...
Space: the final frontier. These are the voyages of the Starship Audiology. Its ongoing mission: to explore strange new research. To seek out new articles and new technology.
Neuromod Devices Ltd, the Irish medical device company which specialises in neuromodulation technologies, has announced the establishment of Neuromod USA Inc., a subsidiary headquartered in Oak Brook, Illinois.